Form 8-K
8-K — Wellgistics Health, Inc.
Accession: 0001493152-26-021718
Filed: 2026-05-07
Period: 2026-05-01
CIK: 0002030763
SIC: 5122 (WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES)
Item: Entry into a Material Definitive Agreement
Item: Financial Statements and Exhibits
Documents
8-K — form8-k.htm (Primary)
EX-10.1 (ex10-1.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K
8-K (Primary)
Filename: form8-k.htm · Sequence: 1
false
0002030763
0002030763
2026-05-01
2026-05-01
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 1,
2026
WELLGISTICS
HEALTH, INC.
(Exact
name of registrant as specified in its charter)
Delaware
001-42530
93-3264234
(State
or other jurisdiction
of
incorporation)
(Commission
File
Number)
(IRS
Employer
Identification
No.)
3000
Bayport Drive
Suite
950
Tampa,
FL 33607
(Address
of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: (844)
203-6092
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common
Stock, $0.0001 par value per share
WGRX
The
Nasdaq Capital Market LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01. Entry into a Material Definitive Agreement.
On
May 1, 2026, Wellgistics, LLC (“Wellgistics”), a wholly owned subsidiary of Wellgistics Health, Inc. (the “Company”),
entered into an Acknowledgment of Indebtedness, Forbearance and Repayment Agreement (the “Forbearance Agreement”) with Marco
Capital, Inc. (“MCI”). The Company, together with certain members of management, also entered into the Forbearance Agreement
for purposes of reaffirming certain guaranty and related obligations.
Under
the Forbearance Agreement, Wellgistics acknowledged approximately $1.77 million in outstanding obligations owed to MCI under that certain
Loan and Security Agreement, dated November 22, 2024, between Wellgistics and MCI. Pursuant to the Forbearance Agreement, MCI agreed
to temporarily forbear from exercising certain rights and remedies arising under the existing loan documents through June 15, 2026, subject
to the terms and conditions set forth therein.
The
Forbearance Agreement provides for bi-weekly payments of $50,000 beginning May 5, 2026. In addition, the agreement provides that a portion
of net proceeds received from future financing transactions by the Company or its affiliates during the forbearance period may be required
to be applied toward repayment of the outstanding obligations, subject to specified percentage thresholds set forth in the agreement.
The
outstanding obligations accrue interest at a rate equal to Term SOFR plus 11.5% per annum beginning May 5, 2026.
The
Forbearance Agreement also contains customary acknowledgments, representations and warranties, reaffirmations of existing guaranties,
covenants, events of default and reservation of rights provisions customary for agreements of this nature.
The
foregoing description of the Forbearance Agreement does not purport to be complete and is qualified in its entirety by reference to the
full text of the Forbearance Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by
reference.
Item
9.01. Financial Statements and Exhibits.
(d)
Exhibits.
The
following exhibits are filed as part of, or incorporated by reference into, this Report.
Exhibit
No.
Description
10.1
Acknowledgement of Indebtedness, Forbearance and Repayment Agreement dated as of May 1, 2026, by and among Marco Capital, Inc., Wellgistics, LLC, Wellgistics Health, Inc., Prashant Patel and Eric Sherb
104*
Cover
Page Interactive Data File (formatted as Inline XBRL)
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date:
May 7, 2026
WELLGISTICS
HEALTH, INC.
By:
/s/
Prashant Patel
Prashant
Patel, President
EX-10.1
EX-10.1
Filename: ex10-1.htm · Sequence: 2
Exhibit
10.1
ACKNOWLEDGMENT
OF INDEBTEDNESS, FORBEARANCE AND REPAYMENT AGREEMENT
This
ACKNOWLEDGMENT OF INDEBTEDNESS, FORBEARANCE AND REPAYMENT AGREEMENT (this “Agreement”) is made as of May 1, 2026 (the
“Effective Date”), by and among Marco Capital, Inc., a Delaware corporation (“MCI”), Wellgistics,
LLC, a Florida limited liability company (“Borrower”), Wellgistics Health, Inc., a Delaware corporation (“Parent
Guarantor”), and Prashant Patel and Eric Sherb (each, a “Management Guarantor” and collectively, the “Management
Guarantors”). Borrower, Parent Guarantor and Management Guarantors are sometimes referred to herein collectively as the “Obligors”,
and MCI, Borrower, Parent Guarantor and Management Guarantors are sometimes referred to herein collectively as the “Parties”.
RECITALS
WHEREAS,
MCI and Borrower are parties to that certain Loan and Security Agreement dated as of November 22, 2024 (as amended, restated, supplemented
or otherwise modified from time to time, the “Loan Agreement”);
WHEREAS,
Parent Guarantor executed and delivered to MCI that certain Guaranty Agreement (the “Parent Guaranty”), pursuant to
which Parent Guarantor absolutely and unconditionally guaranteed the payment and performance of all Obligations;
WHEREAS,
as of May 5, 2026, the aggregate outstanding amount of all Obligations owed by Borrower to MCI equals USD 1,766,131.54 (the “Outstanding
Amount”);
WHEREAS,
certain circumstances exist under the Loan Agreement and the other Loan Documents that entitle MCI to exercise rights and remedies thereunder
and under applicable law, including acceleration of the Obligations and enforcement against the Collateral;
WHEREAS,
Borrower has requested that MCI temporarily forbear from exercising such rights and remedies, and MCI is willing to do so solely on the
terms and conditions set forth herein;
Capitalized
terms used herein and not otherwise defined herein shall have the meanings ascribed to such terms in the Loan Agreement, and all references
in this Agreement to the Loan Agreement and the other Loan Documents shall mean the same as amended, restated, supplemented or otherwise
modified from time to time, except as expressly provided herein.
NOW,
THEREFORE, in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
1. ACKNOWLEDGMENT
OF OBLIGATIONS
1.1. Borrower
hereby irrevocably and unconditionally acknowledges, confirms and agrees that (i) the Outstanding
Amount is due and owing to MCI without dispute, deduction or offset of any kind, (ii) such
amount constitutes valid, binding and enforceable Obligations under the Loan Agreement and
the other Loan Documents, (iii) all Obligations are absolute and presently due (whether or
not accelerated), and (iv) Borrower has no defenses, counterclaims, rights of setoff or other
claims of any nature whatsoever against MCI with respect to the Obligations or otherwise.
Borrower further ratifies and reaffirms all of its obligations, liabilities and duties under
the Loan Agreement and the other Loan Documents, each of which shall remain in full force
and effect.
2. CONDITIONAL
FORBEARANCE
2.1. Subject
strictly to the terms and conditions of this Agreement, MCI hereby agrees, for a limited
period, to forbear from exercising its rights and remedies arising in connection with the
Obligations and the Loan Agreement. Such forbearance is expressly conditioned upon the full
and timely performance by Borrower and the other Obligors of each and every covenant, agreement
and obligation set forth in this Agreement.
2.2. The
parties expressly agree that this Agreement constitutes a limited forbearance agreement only,
and nothing contained herein shall be deemed or construed as (i) a waiver of any Event of
Default, (ii) a waiver of any rights or remedies of MCI, (iii) a reinstatement of the credit
facility, or (iv) a modification of the Loan Agreement or any other Loan Document, except
as expressly set forth herein. Upon the occurrence of any default under this Agreement, MCI’s
agreement to forbear shall automatically and immediately terminate without notice.
2.3 The
period during which MCI agrees to forbear pursuant to this Agreement (the “Forbearance
Period”) shall commence on the Effective Date and shall continue until June 15th, 2026,
unless earlier terminated in accordance with the terms of this Agreement.
3. REPAYMENT
OF OBLIGATIONS
3.1. In
consideration of MCI’s agreement to forbear, Borrower hereby agrees to repay the Outstanding
Amount in accordance with the following terms.
3.2. Borrower
shall make payments to MCI in the amount of Fifty Thousand Dollars (USD 50,000), with the
first such payment due and payable on May 5, 2026, and subsequent payments due every fourteen
(14) days thereafter. All payments shall be made in immediately available funds, without
deduction, setoff or counterclaim, to such account as MCI may designate from time to time.
3.3. Borrower
acknowledges and agrees that all collections and proceeds of Collateral received in any deposit
account subject to MCI’s control shall be automatically applied by MCI to the Obligations,
in such order and manner as MCI may determine in its sole discretion, and shall reduce the
Outstanding Amount.
3.4. Notwithstanding
the foregoing, the entire unpaid balance of the Obligations, after giving effect to all payments
made pursuant to Section 3.2 and all applications of collections pursuant to Section 3.3,
shall become due and payable in full upon the earlier to occur of (i) June 15, 2026, or (ii)
the date that is five (5) Business Days following the receipt by Borrower or any of its affiliates
of net proceeds actually received by Borrower from any equity financing, debt financing,
capital raise or similar transaction, regardless of the form or structure of such transaction;
provided, however, that Borrower shall only be required to apply to the Obligations an amount
equal to (A) ten percent (10%) of the portion of such net proceeds up to $2,500,000, (B)
twenty percent (20%) of the portion of such net proceeds in excess of $2,500,000 and up to
$5,000,000, and (C) thirty percent (30%) of the portion of such net proceeds in excess of
$5,000,000. Borrower shall provide prompt written notice to MCI upon receipt of any such
proceeds.
4. INTEREST
4.1. Commencing
on May 5, 2026, the outstanding Obligations shall accrue interest at an annual rate equal
to Term SOFR (as defined in the Loan Agreement) plus 11.5%, calculated and prorated daily
on the Daily Balance. Such interest shall be payable on demand or, if not sooner paid, upon
repayment in full of the Obligations.
5. COLLATERAL
AND CASH MANAGEMENT
5.1. Borrower
acknowledges and agrees that MCI holds a valid, perfected and first-priority security interest
in and to all Collateral, and that such security interest remains in full force and effect.
Borrower further acknowledges that all proceeds of Collateral are subject to MCI’s
control pursuant to one or more control agreements, including any Deposit Account Control
Agreement.
5.2. Borrower
covenants and agrees that all collections and proceeds of Collateral shall continue to be
deposited directly into accounts subject to MCI’s control, and that Borrower shall
not open, maintain or use any deposit account, nor direct any Account Debtor to remit payment
to any account, except as expressly permitted by MCI in writing. Borrower shall not take
any action that would impair MCI’s control over such accounts or the proceeds therein.
6. CURRENT
REPRESENTATIONS AND WARRANTIES
6.1. Each
Obligor hereby represents and warrants to MCI, as of the Effective Date that: (i) such Obligor
is duly organized or formed, validly existing and in good standing under the laws of its
jurisdiction of organization or formation, as applicable, and has all requisite power and
authority to execute, deliver and perform this Agreement; (ii) the execution, delivery and
performance of this Agreement have been duly authorized by all necessary action on the part
of such Obligor, and this Agreement constitutes the legal, valid and binding obligation of
such Obligor, enforceable against such Obligor in accordance with its terms, subject only
to applicable bankruptcy, insolvency, reorganization and other similar laws affecting creditors’
rights generally and to general principles of equity; (iii) no Insolvency Proceeding has
been commenced by or, to such Obligor’s knowledge, against such Obligor, and such Obligor
has not taken any corporate, limited liability company or other organizational action in
contemplation of any Insolvency Proceeding; (iv) except as previously disclosed to MCI in
writing, no action, suit, arbitration, investigation or other proceeding is pending or, to
such Obligor’s knowledge, threatened against such Obligor or any of its assets that
could reasonably be expected to result in a Material Adverse Change; (v) all financial, operational
and other information delivered by or on behalf of any Obligor to MCI in connection with
the Loan Agreement, this Agreement, the Obligations, the Collateral or any request for forbearance
or accommodation from MCI is true, correct and complete in all material respects and does
not omit to state any material fact necessary to make such information, in light of the circumstances
in which it was furnished, not materially misleading; and (vi) except as expressly disclosed
in this Agreement or in writing to MCI prior to the Effective Date, there exists no fact,
event, condition or circumstance affecting any Obligor, the Obligations, the Collateral or
the enforceability of any Loan Document that has not been disclosed to MCI and that could
reasonably be expected to result in a Material Adverse Change.
6.2. Each
Obligor acknowledges and agrees that MCI is entering into this Agreement, and is agreeing
to the limited forbearance provided herein, in express reliance upon the representations
and warranties set forth in this Section. The representations and warranties contained in
this Section shall survive the execution and delivery of this Agreement and any investigation
by MCI or any of its representatives.
7. AFFIRMATIVE
AND NEGATIVE COVENANTS
7.1. Until
the Obligations have been indefeasibly paid in full, Borrower agrees that it shall not create,
incur, assume or permit to exist any lien on any Collateral without MCI’s prior written
consent, and shall not permit any financing statement or other filing to be made against
the Collateral other than in favor of MCI or as otherwise expressly permitted under the Loan
Agreement.
7.2. Borrower
further agrees that it shall not effect any change in its management, ownership or control
without prior written notice to MCI, and shall promptly provide such financial statements,
reports and other information as MCI may reasonably request. Borrower shall comply in all
respects with the Loan Agreement and all related control account arrangements.
8. REAFFIRMATION
OF GUARANTIES
8.1. Parent
Guarantor hereby absolutely and unconditionally reaffirms, ratifies and confirms all of its
obligations under the Parent Guaranty and agrees that such Parent Guaranty remains in full
force and effect and is not impaired, reduced or discharged in any respect by this Agreement
or any of the transactions contemplated hereby. Without limiting the foregoing, Parent Guarantor
acknowledges and agrees that the Parent Guaranty secures and applies to all Obligations,
including, without limitation, the Obligations as acknowledged, reaffirmed or otherwise referenced
in this Agreement. Parent Guarantor further consents to this Agreement and agrees that its
obligations under the Parent Guaranty are continuing, absolute and unconditional, and shall
not be affected, impaired or released by any forbearance, accommodation, amendment, waiver
or other action or inaction by MCI in connection with the Obligations, this Agreement or
any of the other Loan Documents, and Parent Guarantor hereby waives any defense based on
any such forbearance, accommodation, amendment or other action or inaction.
9. WAIVER
OF DEFENSES BY PARENT GUARANTOR AND MANAGEMENT GUARANTORS
9.1. Parent
Guarantor and each Management Guarantor hereby absolutely, unconditionally and irrevocably
waive any and all defenses, claims, counterclaims, offsets and rights of discharge of any
nature whatsoever that Parent Guarantor or such Management Guarantor may now or hereafter
have in connection with the enforcement of its obligations under this Agreement, the Parent
Guaranty or any of the other Loan Documents, including, without limitation, any defense arising
by reason of: (i) any modification, amendment, supplement, extension, renewal, compromise,
settlement, restructuring or restatement of the Loan Agreement, this Agreement, the Parent
Guaranty or any other Loan Document; (ii) any failure by MCI to give notice of any default
or Event of Default, presentment, demand, protest or notice of protest, notice of dishonor,
notice of acceptance, notice of intent to accelerate, notice of acceleration, or any other
notice or formal demand of any kind; (iii) any failure by MCI to proceed first against Borrower,
any other Obligor, any guarantor or any Collateral before proceeding against Parent Guarantor
or either Management Guarantor; (iv) any impairment, loss, release, substitution, exchange,
surrender, compromise or failure to perfect or continue the perfection of any Collateral
or any guaranty or other credit support; (v) any application, misapplication or reapplication
of payments, proceeds or recoveries by MCI in any manner; (vi) any invalidity, irregularity
or unenforceability, in whole or in part, of any Loan Document; or (vii) any other circumstance
that might otherwise constitute a legal or equitable defense available to a guarantor, surety
or accommodation party.
9.2. Parent
Guarantor and each Management Guarantor further acknowledge and agree that their respective
obligations under this Agreement are independent, continuing, absolute and unconditional,
and shall not be affected, impaired or released by any act or omission of MCI, whether or
not such act or omission might otherwise operate as a legal or equitable discharge of a guarantor
or surety. Parent Guarantor and each Management Guarantor expressly agree that MCI may enforce
its rights against any one or more of them without first seeking to enforce any rights against
Borrower, any other Obligor or any Collateral, and without first exhausting any other remedy
available to MCI.
10. MANAGEMENT
REPRESENTATIONS AND LIMITED GUARANTY
10.1. Each
Management Guarantor hereby represents and warrants, to such Management Guarantor’s
actual knowledge, as of the Effective Date and after reasonable inquiry, that:
a) no
information delivered by or on behalf of Borrower to MCI prior to or as of the Effective
Date in connection with the Loan Agreement, this Agreement or the Obligations contains any
material misstatement of fact or omits to state any material fact necessary to make such
information not materially misleading; and
b) such
Management Guarantor has no knowledge of any fraud, misrepresentation or material omission
in connection with the Loan Documents or the Obligations.
10.2. Each
Management Guarantor acknowledges and agrees that MCI is entering into this Agreement in
express reliance on the foregoing representations.
10.3. Each
Management Guarantor further agrees that, in the event of any breach of the foregoing representations,
such Management Guarantor shall be liable to MCI for all losses, damages, costs and expenses
(including attorneys’ fees) incurred by MCI as a result thereof. The obligations of
each Management Guarantor under this Section are independent and may be enforced directly
by MCI.
10.4 Notwithstanding
anything to the contrary contained in this Agreement, the Loan Agreement, the Parent Guaranty
or any other Loan Document, no Management Guarantor shall have any personal liability for
the payment or performance of the Obligations, and MCI hereby agrees that it shall not seek
to enforce the Obligations against any Management Guarantor in such Person’s individual
capacity; provided, however, that nothing herein shall limit or restrict the liability of
any Management Guarantor arising under this Section 10 with respect to breaches of the representations
and warranties expressly set forth herein.
11. EVENTS
OF DEFAULT; REMEDIES
11.1. The
occurrence of (i) any failure by Borrower or any other Obligor to comply with any provision
of this Agreement, or (ii) any Event of Default under the Loan Agreement or any other Loan
Document, shall constitute an immediate Event of Default hereunder. Upon the occurrence of
any such Event of Default, all Obligations shall, at MCI’s option, become immediately
due and payable, and MCI may exercise any and all rights and remedies available under the
Loan Agreement, the other Loan Documents and applicable law, without further notice or demand.
11.2. Notwithstanding
the foregoing, with respect to a monetary default arising solely from Borrower’s failure
to make a scheduled payment pursuant to Section 3.2, MCI shall provide Borrower with two
(2) Business Days’ written notice of such failure prior to exercising remedies solely
on account of such monetary default. Notice delivered by email to Borrower shall constitute
valid and sufficient written notice for purposes of this Section. For the avoidance of doubt,
this limited cure period shall not apply to any other Event of Default under this Agreement
or the Loan Agreement.
12. INDEMNIFICATION
AND EXPENSES
12.1. Borrower
hereby agrees to pay, reimburse, indemnify, defend and hold harmless MCI and its affiliates,
and each of their respective officers, directors, managers, employees, attorneys, advisors,
agents, representatives, successors and assigns (collectively, the “Indemnified Parties”),
from and against any and all losses, claims, damages, liabilities, penalties, judgments,
costs and expenses, including, without limitation, reasonable and documented attorneys’
fees and disbursements, incurred by any Indemnified Party in connection with or arising out
of: (i) the negotiation, preparation, execution, delivery, administration, enforcement or
performance of this Agreement; (ii) any workout, restructuring, collection effort, enforcement
action, litigation, dispute, motion, appeal, bankruptcy matter or other proceeding arising
out of or relating to the Obligations, the Collateral, this Agreement, the Loan Agreement
or any of the other Loan Documents; or (iii) any failure by Borrower or any other Obligor
to comply with any provision of this Agreement or any of the other Loan Documents.
12.2. All
amounts payable under this Section shall be payable by Borrower to MCI on demand, shall constitute
Obligations for all purposes under the Loan Agreement and this Agreement, shall be secured
by the Collateral to the fullest extent provided in the Loan Documents, and shall accrue
interest in accordance with the terms of the Loan Agreement from the date incurred or paid
by MCI until reimbursed in full by Borrower. The obligations of Borrower under this Section
shall survive the termination of this Agreement and the repayment of the Obligations.
12.3. Upon
the indefeasible payment in full of all Obligations, MCI shall promptly (and in any event
within five (5) Business Days) execute and deliver such documents and take such actions as
are reasonably necessary to release its liens and security interests in the Collateral and
terminate any related control agreements and financing statements, in each case to the extent
within MCI’s control.
13. RESERVATION
OF RIGHTS
13.1. MCI
hereby expressly reserves all of its rights and remedies under the Loan Agreement, the other
Loan Documents and applicable law. No delay or failure by MCI to exercise any right or remedy
shall constitute a waiver thereof, and no waiver shall be effective unless set forth in a
writing executed by MCI.
14. MISCELLANEOUS
14.1. This
Agreement shall be governed by and construed in accordance with the laws of the State of
New York, without giving effect to any conflicts of law principles that would require the
application of the laws of any other jurisdiction.
14.2. Each
Obligor hereby irrevocably and unconditionally agrees that any legal action, suit or proceeding
arising out of or relating to this Agreement, the Loan Agreement, any other Loan Document
or the transactions contemplated hereby or thereby may be brought in the federal courts of
the United States of America located in Miami-Dade County, Florida, and, to the extent such
courts do not have jurisdiction, in the state courts of the State of Florida located in Miami-Dade
County, and each Obligor hereby irrevocably submits to the jurisdiction of such courts and
agrees that it will not assert, by way of motion or otherwise, any claim that it is not subject
to the jurisdiction of such courts, that the venue of any such proceeding is improper or
that any such proceeding is brought in an inconvenient forum. Notwithstanding the foregoing,
nothing herein shall limit the right of MCI to bring any action or proceeding against any
Obligor or its property in any other jurisdiction.
14.3. EACH
OBLIGOR HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A
TRIAL BY JURY IN RESPECT OF ANY LITIGATION ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS
AGREEMENT, THE LOAN AGREEMENT, ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY
OR THEREBY, AND AGREES THAT ANY SUCH LITIGATION SHALL BE TRIED BEFORE A COURT AND NOT BEFORE
A JURY.
14.4. This
Agreement constitutes the entire agreement among the parties with respect to the subject
matter hereof and supersedes all prior agreements, understandings, negotiations and discussions,
whether oral or written, relating thereto; provided, however, that nothing contained herein
shall be deemed to amend, modify, waive or otherwise affect any provision of the Loan Agreement
or any other Loan Document, except as expressly set forth herein, and each of the Loan Documents
is hereby ratified and confirmed in all respects.
14.5. This
Agreement may not be amended, modified or supplemented except by a written instrument executed
by MCI. No waiver by MCI of any provision of this Agreement or any other Loan Document, or
of any Event of Default, shall be effective unless in writing and signed by MCI, and no such
waiver shall be deemed to be a waiver of any other or subsequent breach or default. No failure
or delay by MCI in exercising any right, power or remedy shall operate as a waiver thereof,
nor shall any single or partial exercise thereof preclude any other or further exercise thereof
or the exercise of any other right, power or remedy.
14.6. This
Agreement shall be binding upon and inure to the benefit of the parties hereto and their
respective successors and assigns; provided, however, that Borrower and the other Obligors
may not assign or transfer any of their rights or obligations hereunder without the prior
written consent of MCI, and any attempted assignment in violation of the foregoing shall
be null and void. MCI may assign, transfer or participate its rights and obligations under
this Agreement in accordance with the Loan Agreement without the consent of any Obligor.
14.7. If
any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect
under any applicable law, such invalidity, illegality or unenforceability shall not affect
any other provision of this Agreement, and this Agreement shall be construed as if such invalid,
illegal or unenforceable provision had never been contained herein, to the fullest extent
permitted by law.
14.8. This
Agreement may be executed in any number of counterparts, each of which shall be deemed an
original and all of which taken together shall constitute one and the same instrument. Delivery
of an executed counterpart of a signature page of this Agreement by electronic transmission
in portable document format (PDF), by electronic mail or by any other electronic means shall
be effective as delivery of a manually executed counterpart hereof.
14.9. The
obligations of the Obligors under this Agreement shall be joint and several, and each Obligor
acknowledges and agrees that MCI may proceed against any one or more Obligors without being
required to proceed against any other Obligor or to exhaust any remedy against Borrower,
any guarantor or any Collateral.
14.10. Time
is of the essence with respect to all obligations of Borrower and the other Obligors under
this Agreement.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]
IN
WITNESS WHEREOF, the parties hereto have executed this ACKNOWLEDGMENT OF INDEBTEDNESS, FORBEARANCE AND REPAYMENT AGREEMENT as of
the Effective Date first written above.
BORROWER:
PARENT GUARANTOR:
WELLGISTICS, LLC,
WELLGISTICS
HEALTH, INC.
a Florida limited liability company
(formerly DANAM HEALTH, INC.), a
Delaware corporation.
By:
WELLGISTICS HEALTH, INC.
a Delaware corporation.
By:
/s/ Prashant Patel
Its:
Sole Member
Name:
Prashant Patel
Title:
CEO
By:
/s/ Prashant Patel
Name:
Prashant Patel
MANAGEMENT GUARANTOR:
Title:
CEO
By:
/s/ Prashant Patel
MCI:
Name:
Prashant Patel
Title:
CEO
MARCO CAPITAL, INC.,
a Delaware corporation
MANAGEMENT GUARANTOR:
By:
/s/ Peter D. Spradling
By:
/s/ Eric Sherb
Name:
Peter D. Spradling
Name:
Eric Sherb
Title:
CEO
Title:
CFO
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 8
v3.26.1
Cover
May 01, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 01, 2026
Entity File Number
001-42530
Entity Registrant Name
WELLGISTICS
HEALTH, INC.
Entity Central Index Key
0002030763
Entity Tax Identification Number
93-3264234
Entity Incorporation, State or Country Code
DE
Entity Address, Address Line One
3000
Bayport Drive
Entity Address, Address Line Two
Suite
950
Entity Address, City or Town
Tampa
Entity Address, State or Province
FL
Entity Address, Postal Zip Code
33607
City Area Code
(844)
Local Phone Number
203-6092
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
Common
Stock, $0.0001 par value per share
Trading Symbol
WGRX
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
true
Elected Not To Use the Extended Transition Period
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 7A
-Section B
-Subsection 2
+ Details
Name:
dei_EntityExTransitionPeriod
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration